RSS   Newsletter   Contact   Advertise with us
Post Online Media

Antares Pharma appoints Fred M. Powel as CFO

Antares PharmaAntares Pharma, a developer and marketer of parenteral pharmaceuticals, announced the appointment of Fred M. Powell to the position of senior vice president, chief financial officer.

Most recently, Mr. Powell served as Vice President and Chief Financial Officer for Celator Pharmaceuticals.

Article continues below

READ MORE Antares Pharma elected Eamonn P. Hobbs to board of directors

Prior to joining Celator, Mr. Powell was the chief financial officer of OraPharma until its acquisition by Valeant Pharmaceuticals in June, 2012.

He was also chief financial officer of BMP Sunstone Corporation. He also held senior finance and administration positions at Eximias Pharmaceutical Corporation, Innaphase Corporation and ERT.

Mr. Powell began his career with KPMG Peat Marwick and is a graduate of Penn State University.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy